EGIIX | MINDX | EGIIX / MINDX | |
Total Expense Ratio | 1.23 | 1.22 | 101% |
Annual Report Gross Expense Ratio | 1.23 | 1.22 | 101% |
Fund Existence | 16 years | 20 years | - |
Gain YTD | 3.156 | 1.856 | 170% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 269M | 763M | 35% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | -0.75 | -13.60 | 5% |
Returns for 3 years | 23.69 | 9.95 | 238% |
Returns for 5 years | 52.39 | 40.05 | 131% |
Returns for 10 years | 57.19 | -6.54 | -875% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
NGRRX | 33.72 | 0.26 | +0.78% |
Nuveen International Value I | |||
LIDFX | 9.49 | 0.07 | +0.74% |
Lord Abbett International Value F | |||
AEPIX | 25.60 | 0.10 | +0.39% |
Allspring Managed Acct Corebuilder EPI | |||
ASVHX | 9.86 | -0.01 | -0.10% |
American Century Small Cap Value G | |||
FBTIX | 28.70 | -0.21 | -0.73% |
Fidelity Advisor Biotechnology I |